Patents by Inventor John W. Hayes

John W. Hayes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hazardous agent injection system
    Patent number: 12357642
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: July 15, 2025
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • IMPROVED CLOCK SECURITY FOR STATISTICAL OBJECT GENERATION
    Publication number: 20250158812
    Abstract: A method includes operating an activation agent to access a clock value and at least one original object. The activation agent communicates said clock value and said at least one original object to an object activation service. The object activation service is operated to generate keying information and expiration criteria for the at least one original object. The keying information includes a clock offset and an async reset value. The object activation service communicates the keying information and the expiration criteria to the activation agent.
    Type: Application
    Filed: November 9, 2023
    Publication date: May 15, 2025
    Inventor: John W. Hayes
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20250114297
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 16, 2024
    Publication date: April 10, 2025
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • STATISTICAL OBJECT IDENTIFICATION
    Publication number: 20250061191
    Abstract: A mechanism is disclosed to communicate an original object (12S) without requiring the sending of the complete original object. A representation of the original object (12S), a statistical object (14S), is generated by one entity and is communicated to a second entity. The second entity receives the statistical object (14S), and identifies it as being generated from an original object (12S). If the second entity is unable to unambiguously identify the statistical object (14S), the second entity records the partial identity progress and associated communications characteristics information (22). The amount of information communicated during this process is much smaller than the original object (12S), greatly improving the speed and efficiency of communicating an original object (12S). If the second entity is unable to match the received statistical object (14S) to any stored statistical object, an attack measurement (13S) is generated, and further processing of the received statistical object (14S) ends.
    Type: Application
    Filed: August 18, 2023
    Publication date: February 20, 2025
    Inventor: John W. Hayes
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20230390187
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Needle assisted jet injection administration of testosterone compositions
    Patent number: 11771646
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: October 3, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Hazardous Agent Injection System
    Publication number: 20230104341
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: October 5, 2022
    Publication date: April 6, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Hazardous agent injection system
    Patent number: 11497753
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: November 15, 2022
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Transporting fibre channel over ethernet
    Patent number: 11108591
    Abstract: Methods and apparatus for the Transporting of Fibre Channel data over Ethernet are disclosed. In one embodiment of the invention, Fibre Channel data frame and primitive signals are transported over Ethernet instead of using the Fibre Channel FC-1 and FC-0 protocols. This allows less expensive Ethernet equipment and devices to transport and perform services for Fibre Channel connected devices without having a physical Fibre Channel interface. The ability to provide Fibre Channel services and functions without having a physical Fibre Channel interface allows existing Ethernet equipment to be placed into service as SAN components without modification.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: August 31, 2021
    Inventors: Alex E. Henderson, Walter E. Croft, John W Hayes, Linda Elaine Eaton Hayes
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20210015741
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 2, 2020
    Publication date: January 21, 2021
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Needle assisted jet injection administration of testosterone compositions
    Patent number: 10821072
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: November 3, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Hazardous Agent Injection System
    Publication number: 20200163975
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: December 16, 2019
    Publication date: May 28, 2020
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Hazardous agent injection system
    Patent number: 10555954
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: February 11, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20190030260
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 31, 2019
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Method for using authenticated requests to select network routes
    Patent number: 10187299
    Abstract: The present invention enables the selection of network routes based on a combination of traditional route table entries and identity policy information determined dynamically for each network session. This enables a network operator to apply different policies to network entities presenting differing identity credentials. It also allows network operators to block access to networks and network resources when identity credentials are not provided or are unauthorized.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: January 22, 2019
    Assignee: BlackRidge Technology Holdings, Inc.
    Inventor: John W. Hayes
  • Method for statistical object indentification
    Patent number: 9973499
    Abstract: A mechanism to activate an original object (12S) so that statistical objects (14S) generated from the original object can be recognized using statistical object identification is disclosed. An object activation agent (48) with a clock (47) and at least one original object (12S) communicates the original object (12S) and time from the clock (47) to an object activation service (50). The object activation service (50) provides and communicates keying information (61) and expiration criterion (63) for at least one of said original objects (12S) back to the object activation agent (48).
    Type: Grant
    Filed: January 26, 2016
    Date of Patent: May 15, 2018
    Assignee: BlackRidge Technology Holdings, Inc.
    Inventors: John W. Hayes, Christopher Luis Hamlin, Charles Andrew Gram
  • Needle assisted jet injection administration of testosterone compositions
    Patent number: 9950125
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: April 24, 2018
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Hazardous Agent Injection System
    Publication number: 20170361021
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: September 1, 2017
    Publication date: December 21, 2017
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Method for using authenticated requests to select network routes
    Publication number: 20170310579
    Abstract: The present invention enables the selection of network routes based on a combination of traditional route table entries and identity policy information determined dynamically for each network session. This enables a network operator to apply different policies to network entities presenting differing identity credentials. It also allows network operators to block access to networks and network resources when identity credentials are not provided or are unauthorized.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 26, 2017
    Inventor: John W. Hayes
  • Hazardous agent injection system
    Patent number: 9750881
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: September 5, 2017
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes